Generic Portal

— Research Explorer

Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1186/s12885-020-07100-z
Final published version

Maryam Soleimani Dodaran
Simone Borgoni
Emre Sofyall
Pernette J. Verschure
Stefan Wiemann
Perry D. Moerland
Antoine H. C. van Kampen

Original language	English
Article number	676
Journal	BMC cancer
Volume	20
Issue number	1
DOIs	https://doi.org/10.1186/s12885-020-07100-z
Publication status	Published - 19 Jul 2020

Research areas

Breast cancer, DNA methylation, Endocrine therapy, Resistance, Survival, T47D

ID: 12537583